Multiple components of ganglion cell desensitization in response to prosthetic stimulation.
Retinal prostheses aim to restore functional vision to those blinded by outer retinal diseases using electric stimulation of surviving neurons. Previous work indicates that repetitive stimulation with stimuli that activate the synaptic network reduces the sensitivity of retinal neurons to further stimulation. Such desensitization may contribute to the fading of visual percepts over time reported by human subjects. Here, we show that desensitization may be more complex than previously considered. We recorded spike trains from rabbit retinal ganglion cells and found that desensitization persists in the presence of inhibitory blockers (strychnine and picrotoxin), indicating amacrine cell inhibition is not solely responsible for reducing sensitivity in response to electric stimulation. The threshold for direct activation of the ganglion cell changes little during the simultaneous desensitization of the synaptically mediated response, indicating that desensitization likely occurs upstream of the spike generator. In addition to rapid desensitization acting over hundreds of milliseconds (τ = 176.4 ± 8.8 ms), we report the presence of slow acting desensitization with a time course of seconds (τ = 14.0 ± 1.1 s). The time courses of the two components of desensitization that we found are similar to the two phases of brightness fading seen in human subjects. This suggests that the reduction in ganglion cell firing due to desensitization may be responsible for the fading of visual percepts over time in response to prosthetic stimulation.
Center for Innovative Visual Rehabilitation, Boston VA Healthcare System, 150 South Huntington Ave, Boston, MA 02130, USA.
Daniel K
DK
Freeman
Shelley I
SI
Fried
D000200:Action Potentials / Q000502:physiology*; D000818:Animals; D008959:Models, Neurological; D010775:Photic Stimulation / Q000379:methods*; D011474:Prosthesis Design / Q000379:methods; D011817:Rabbits; D012165:Retinal Ganglion Cells / Q000502:physiology*; D057488:Visual Prosthesis / Q000592:standards
Arch Ophthalmol. 2009 Apr;127(4):398-401
19365014
Exp Eye Res. 2009 Dec;89(6):972-9
19766116
J Neurosci. 2009 Oct 7;29(40):12374-83
19812313
J Neurosci. 2007 May 30;27(22):5994-6005
17537971
J Neural Eng. 2007 Mar;4(1):S1-6
17325407
J Physiol. 2002 Feb 1;538(Pt 3):787-802
11826165
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5411-6
9144251
IEEE Trans Biomed Eng. 2008 Jun;55(6):1744-53
18714839
Neuroscience. 2002;115(4):1109-17
12453483
Vis Neurosci. 1994 Jan-Feb;11(1):111-8
8011574
Prog Brain Res. 2005;147:205-18
15581708
Science. 2002 Feb 8;295(5557):1022-5
11834821
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1486-96
15790920
Nat Neurosci. 2005 Dec;8(12):1690-7
16286933
J Neurophysiol. 2006 Feb;95(2):970-8
16236780
Neurosci Biobehav Rev. 2008;32(3):352-66
18035416
J Neurosci. 2000 Jun 1;20(11):4286-99
10818164
J Neurophysiol. 2009 Dec;102(6):3689-97
19846619
Mol Neurobiol. 2007 Dec;36(3):205-23
17955196
Vis Neurosci. 1992 Dec;9(6):535-53
1450106
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2606-12
16723477
J Neurophysiol. 2005 Dec;94(6):3662-9
16148275
Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3533-43
12882804
J Neurosci. 1993 Dec;13(12):5334-55
8254378
J Neurosci. 2003 Sep 24;23(25):8743-51
14507974
J Neurosci. 2008 Apr 23;28(17):4446-56
18434523
J Neurophysiol. 2001 Apr;85(4):1351-6
11287459
J Neurophysiol. 2009 Apr;101(4):1972-87
19193771
Vis Neurosci. 2008 Jul-Aug;25(4):535-48
18634718
Network. 2008;19(4):253-85
18991144
J Neural Eng. 2005 Mar;2(1):S16-21
15876650
J Biomater Sci Polym Ed. 2007;18(8):1031-55
17705997
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5017-25
19608533
Annu Rev Biomed Eng. 2005;7:361-401
16004575
Science. 1997 May 9;276(5314):949-52
9139658
J Neurophysiol. 2009 Nov;102(5):2982-93
19741103